An Interferon Sparing Strategy of Sofosbuvir Plus Ribavirin for the Treatment of Recently Acquired Hepatitis C Infection
Phase of Trial: Phase IV
Latest Information Update: 15 Apr 2015
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms DARE-C II
- 27 Oct 2014 Trial phase is changed from phase II to phase IV as reported by ClinicalTrials.gov record.
- 27 Oct 2014 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 11 Jul 2014 New trial record